Trials / Completed
CompletedNCT00536068
Platelet Inhibition by Aspirin, Acetaminophen and NSAID
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Kantonsspital Graubünden · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.
Detailed description
An in vivo study on healthy volunteers with combinations of well established drugs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acetylsalicylic acid, acetaminophen, diclofenac, naproxen, placebo | 1. Acetylsalicylic acid 100mg/po and acetaminophen 3x1g/po for 4 days 2. Acetylsalicylic acid 100mg/po and diclofenac 3x50mg/po for 4 days 3. Acetylsalicylic acid 100mg/po and naproxen 3x250mg/po for 4 days 4. Acetylsalicylic acid 100mg/po and placebo 3x1/po for 4 days |
Timeline
- Start date
- 2006-08-01
- Completion
- 2007-08-01
- First posted
- 2007-09-27
- Last updated
- 2007-09-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT00536068. Inclusion in this directory is not an endorsement.